v3.26.1
Balance Sheet Components (Tables)
 6 Months Ended
Jun. 30, 2026
Balance Sheet Related Disclosures [Abstract]  
Schedule of Prepaid Expenses and Other Current Assets

The following table presents the components of prepaid expenses and other current assets as of June 30, 2026 and December 31, 2025 (in thousands):

 

 

June 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

Prepaid clinical expenses

 

$

2,810

 

 

$

4,020

 

Interest and investment receivables

 

 

1,171

 

 

 

298

 

Prepaid expenses

 

 

658

 

 

 

1,069

 

Other current assets

 

 

542

 

 

 

20

 

Prepaid insurance

 

 

47

 

 

 

530

 

Total prepaid expenses and other current assets

 

$

5,228

 

 

$

5,937

 
Schedule of Components of Property and Equipment

The following table presents the components of property and equipment, net as of June 30, 2026 and December 31, 2025 (in thousands):

 

 

June 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

Computer hardware and software

 

$

416

 

 

$

461

 

Laboratory equipment

 

 

299

 

 

 

1,844

 

Leasehold improvements

 

 

224

 

 

 

709

 

Furniture and fixtures

 

 

165

 

 

 

165

 

Property and equipment, gross

 

 

1,104

 

 

 

3,179

 

Less: accumulated depreciation

 

 

(938

)

 

 

(1,979

)

Property and equipment, net

 

$

166

 

 

$

1,200

 
Schedule of Components of Other Assets, Net

The following table presents the components of other assets as of June 30, 2026 and December 31, 2025 (in thousands):

 

 

June 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

Finance lease right-of-use assets

 

$

1,035

 

 

$

1,513

 

Long-term prepaid clinical expenses

 

 

402

 

 

 

693

 

Operating lease right-of-use assets

 

 

235

 

 

 

1,159

 

Other assets

 

 

280

 

 

 

149

 

Long-term prepaid contract manufacturing costs

 

 

98

 

 

 

111

 

Total other assets

 

$

2,050

 

 

$

3,625

 

 
Components of Accrued Expenses and Other Current Liabilities

The following table presents the components of accrued expenses and other current liabilities as of June 30, 2026 and December 31, 2025 (in thousands):

 

 

June 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

Accrued clinical and nonclinical study costs

 

$

6,177

 

 

$

6,196

 

Accrued compensation and related expenses

 

 

2,709

 

 

 

4,356

 

Other current liabilities

 

 

1,764

 

 

 

2,323

 

Accrued contract manufacturing

 

 

1,104

 

 

 

1,341

 

Accrued property and equipment

 

 

—

 

 

 

206

 

Total accrued expenses and other current liabilities

 

$

11,754

 

 

$

14,422